Meredith (MDP) Tops Q4 EPS by 26c

Meredith (NYSE: MDP) reported Q4 EPS of $0.74, $0.26 better than the analyst estimate of $0.48. Revenue for the quarter came in at $718 million versus the consensus estimate of $690.22 million.

For earnings history and earnings-related data on Medexus Pharmaceuticals Inc (MDP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c